spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Scripps Research Institute 

 HSMN NewsFeed - 1 Jun 2021
Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2020
OncoSec Announces Appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jun 2020
Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2020
Seneca Biopharma Announces Executive Appointments and Key Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2020
Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2019
Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 30 Apr 2019
Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2017
IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Feb 2017
Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 28 Nov 2016
Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2016
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2016
Abide Therapeutics Appoints Richard N. Kender to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2016
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D., as Director of Biology Based in San Diego
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Sep 2015
Akebia Therapeutics Announces Additions to its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2015
Celgene Receives Antitrust Clearance for Receptos Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Oct 2014
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 29 Jul 2014
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2014
Edico Genome Raises $10 Million in Series A Financing to Commercialize DRAGEN Chip to Overcome Sequencing Data Analysis Bottleneck
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2013
Senesco Announces Letter of Intent to Merge with Fabrus
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Diagnostics Regulatory
 HSMN NewsFeed - 4 Mar 2013
Trovagene Appoints Mark Erlander, Ph.D. as Chief Scientific Officer
Diagnostics Personnel
 HSMN NewsFeed - 13 Nov 2012
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 28 Oct 2011
Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 May 2010
Dr. John Mendlein Joins aTyr Pharma as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Mar 2010
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 9 Feb 2010
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 11 Jan 2010
Regulus Therapeutics Appoints Zachary A. Zimmerman, Ph.D., Director of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Receptos Completes $25M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Apr 2009
J. Michael Cook to Retire from Lilly Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 23 Jun 2008
Immune Design Announces $18 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Biogen Idec Announces Slate of Directors for Annual Meeting of Shareholders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Anaphore, Inc Receives $8M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Feb 2008
5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
Venture Capital Personnel
 HSMN NewsFeed - 23 Jan 2008
EyeGate Pharma Appoints Michael A. Patane to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2007
Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Sep 2007
Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2007
Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Aug 2007
Abraxis BioScience and The Scripps Research Institute Enter Exclusive Licensing Agreement for the Worldwide Development and Commercialization of a Novel Epothilone Therapeutic for the Treatment of Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Jul 2007
EyeGate Pharma Announces Executive Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 10 Jul 2007
ImClone Systems Appoints Thomas F. Deuel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2007
Poniard Pharmaceuticals Announces Results of Picoplatin Phase 2 Trial That Confirm and Extend Survival Benefit in Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2007
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2007
Poniard Pharmaceuticals Appoints Ronald A. Martell President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Mar 2007
Rincon Pharmaceuticals Appoints Dr. Peter B. Heifetz as Chief Scientific Officer, Drs. Jacqueline J. Johnson and Alan J. Lewis to Board of Directors, and Drs. Katherine S. Bowdish and Mich B. Hein to Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
Scripps Research Institute
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!